B. Dalton

523 total citations
16 papers, 415 citations indexed

About

B. Dalton is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B. Dalton has authored 16 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B. Dalton's work include Pulmonary Hypertension Research and Treatments (6 papers), Vascular Anomalies and Treatments (4 papers) and Sports Performance and Training (3 papers). B. Dalton is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Vascular Anomalies and Treatments (4 papers) and Sports Performance and Training (3 papers). B. Dalton collaborates with scholars based in Australia, United Kingdom and Switzerland. B. Dalton's co-authors include Lars R. McNaughton, Geoff Strange, Eli Gabbay, Leland W.K. Chung, Janet Roddy, J. Deague, David Playford, Trevor J. Williams, Anne Keogh and John Zalcberg and has published in prestigious journals such as European Journal of Applied Physiology, International Journal of Sports Medicine and International Journal of Cardiology.

In The Last Decade

B. Dalton

16 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Dalton Australia	11	157	122	101	74	71	16	415
Christoph Ahlgrim Germany	14	46 0.3×	73 0.6×	58 0.6×	63 0.9×	17 0.2×	34	488
E.M. Pouw Netherlands	9	447 2.8×	28 0.2×	41 0.4×	45 0.6×	37 0.5×	13	577
Adam M. Coughlin United States	7	79 0.5×	13 0.1×	49 0.5×	54 0.7×	7 0.1×	15	385
Mirjana Zlatković‐Švenda Serbia	11	71 0.5×	12 0.1×	29 0.3×	40 0.5×	40 0.6×	39	502
Bojan Knap Slovenia	10	22 0.1×	58 0.5×	24 0.2×	22 0.3×	17 0.2×	32	359
Nieca Goldberg United States	9	31 0.2×	27 0.2×	19 0.2×	61 0.8×	4 0.1×	17	363
Hiroyasu Mori Japan	12	15 0.1×	98 0.8×	18 0.2×	8 0.1×	152 2.1×	37	638
Peter Garcia Webb Australia	6	21 0.1×	20 0.2×	307 3.0×	23 0.3×	138 1.9×	6	504
Robert E. Wills United States	7	44 0.3×	48 0.4×	26 0.3×	84 1.1×	10 0.1×	10	456
Francisco J. Díaz Spain	10	30 0.2×	19 0.2×	23 0.2×	18 0.2×	22 0.3×	31	317

Countries citing papers authored by B. Dalton

Since Specialization

Citations

This map shows the geographic impact of B. Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Dalton more than expected).

Fields of papers citing papers by B. Dalton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Dalton. The network helps show where B. Dalton may publish in the future.

Co-authorship network of co-authors of B. Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of B. Dalton. A scholar is included among the top collaborators of B. Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Dalton. B. Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dalton, B., et al.. (2013). Reducing Clinical Trial Monitoring Resource Allocation and Costs Through Remote Access to Electronic Medical Records. Journal of Oncology Practice. 9(1). e13–e16. 19 indexed citations

Chan, Derek, et al.. (2013). Screening and management of cardiovascular disease in Australian adults with HIV infection. Sexual Health. 10(6). 495–501. 10 indexed citations

Dalton, B., et al.. (2012). A novel, 12-week, nurse-led motivation and education programme has no effect on serum phosphate levels in haemodialysis patients. eCite Digital Repository (University of Tasmania). 8(2). 82–86. 4 indexed citations

Chan, Derek, et al.. (2012). Screening and management of renal disease in human immunodeficiency virus‐infected patients in Australia. Internal Medicine Journal. 43(4). 410–416. 5 indexed citations

Dalton, B., et al.. (2011). Vascular function and mortality in haemodialysis patients: A pilot study. Archives of cardiovascular diseases. 104(10). 518–523. 8 indexed citations

Strange, Geoff, Anne Keogh, B. Dalton, & Eli Gabbay. (2011). Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension. Expert Review of Pharmacoeconomics & Outcomes Research. 11(3). 253–263. 5 indexed citations

Steele, Peter, Geoff Strange, John Wlodarczyk, et al.. (2010). Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?. BMC Cardiovascular Disorders. 10(1). 9–9. 13 indexed citations

Jing, Zhi‐Cheng, Geoff Strange, Hong Gu, et al.. (2010). Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 29(2). 150–156. 16 indexed citations

Keogh, A., Geoff Strange, Eugene Kotlyar, et al.. (2010). Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report. Internal Medicine Journal. 41(3). 235–244. 29 indexed citations

10.

Keogh, Anne, Geoff Strange, K. McNeil, et al.. (2009). The bosentan patient registry: long‐term survival in pulmonary arterial hypertension. Internal Medicine Journal. 41(3). 227–234. 28 indexed citations

11.

Strange, Geoff, Leland W.K. Chung, B. Dalton, et al.. (2008). Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Internal Medicine Journal. 39(10). 682–691. 78 indexed citations

12.

Dalton, B., et al.. (2004). No relationship between low-density lipoproteins and endothelial function in hemodialysis patients. International Journal of Cardiology. 99(2). 307–314. 5 indexed citations

13.

McNaughton, Lars R., et al.. (1999). Sodium bicarbonate can be used as an ergogenic aid in high-intensity, competitive cycle ergometry of 1 h duration. PubMed. 80(1). 64–69. 63 indexed citations

14.

McNaughton, Lars R., et al.. (1999). Inosine Supplementation Has No Effect on Aerobic or Anaerobic Cycling Performance. International Journal of Sport Nutrition. 9(4). 333–344. 25 indexed citations

15.

McNaughton, Lars R., et al.. (1998). The effects of creatine supplementation on high-intensity exercise performance in elite performers. European Journal of Applied Physiology. 78(3). 236–240. 44 indexed citations

16.

Dalton, B., et al.. (1997). Circadian Rhythms Have No Effect on Cycling Performance. International Journal of Sports Medicine. 18(7). 538–542. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact